Table 2.
Correlation between treatment selection and patient outcomes
| Death (n = 32) | Survival (n = 208) | P-value | ||
|---|---|---|---|---|
| Corticosteroids | 24 (75%) | 72 (35%) | 0.001 > * | |
| Immunosuppressant drugs | 7 (29%) | 8 (4%) | 0.001 > * | |
| Anti-fibrotic drugs | 4 (13%) | 16 (8%) | 0.318** | |
| Experienced Acute Exacerbation (n = 26) | Non-Experienced Acute Exacerbation (n = 214) | P-value | ||
| Corticosteroids | 26 (100%) | 70 (33%) | 0.001 > * | |
| Immunosuppressant drugs | 8 (31%) | 7 (3%) | 0.001 > * | |
| Anti-fibrotic drugs | 1 (4%) | 1 (0.5%) | 0.705** |
* Pearson chi-square test. ** Fisher’s exact test. Bold values are statistically significant (P < 0.05)